Personalized prescription of ACEI/ARBs for hypertensive COVID-19 patients

Personalized prescription of ACEI/ARBs for hypertensive COVID-19 patients

The COVID-19 pandemic has prompted an international effort to develop and repurpose medications and procedures to effectively combat the disease. Several groups have focused on the potential treatment utility of angiotensin-converting-enzyme inhibitors (ACEIs) and angiotensin-receptor blockers (ARBs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bertsimas, D, Borenstein, A, Mingardi, L, Nohadani, O, Orfanoudaki, A, Stellato, B, Wiberg, H, Sarin, P, Varelmann, DJ, Estrada, V, Macaya, C, Gil, IJN
Formato:	Journal article
Lenguaje:	English
Publicado:	Springer Nature 2021

Ejemplares similares

Personalized prescription of ACEI/ARBs for hypertensive COVID-19 patients
por: Bertsimas, Dimitris, et al.
Publicado: (2021)

Effect of ACEi and ARBs vs Non ACEi/ARBs in Hypertension with Respect to Renal Outcomes in COVID-19 Infection: A Retrospective Cohort Study
por: S Ravitej, et al.
Publicado: (2022-11-01)

Association of ACEi/ARB Use and Clinical Outcomes of COVID-19 Patients With Hypertension
por: Jing Ma, et al.
Publicado: (2021-05-01)

ACEIs and ARBs and Their Correlation with COVID-19: A Review
por: Yehualashet AS, et al.
Publicado: (2020-09-01)

The Potential Role of ACEi and ARBs in COVID-19; A Perspective
por: Ahmad Hammad Hassan
Publicado: (2020-12-01)

Antihypertensive Therapy by ACEI/ARB Is Associated With Intestinal Flora Alterations and Metabolomic Profiles in Hypertensive Patients
por: Ying Dong, et al.
Publicado: (2022-03-01)

MicroRNA Expression Profile in CAD Patients and the Impact of ACEI/ARB
por: Martina Weber, et al.
Publicado: (2011-01-01)

Final results of BIRCOV trial (ARB, ACEI, DRi in COVID-19)
por: D.D. Ivanov, et al.
Publicado: (2021-09-01)

Comparison of Effects of ACEIs and ARBs on Albuminuria and Hyperkalemia in Indonesian Hypertensive Type 2 Diabetes Mellitus Patients
por: Putri S. Agustina, et al.
Publicado: (2020-01-01)

Effects of ACEI/ARB or CCB use on atrial fibrillation in hypertensive patients following permanent pacemaker implantation
por: Zhijie Liu, et al.
Publicado: (2023-06-01)

Association of ACEI/ARB, inflammatory cytokines, and antiviral drugs with liver dysfunction in patients with hypertension and COVID-19
por: Dong Xiang, et al.
Publicado: (2021-05-01)

Comparing clinical outcomes of ARB and ACEi in patients hospitalized for acute COVID-19
por: Seiji Hamada, et al.
Publicado: (2023-07-01)

ARNI versus ACEI/ARB in Reducing Cardiovascular Outcomes after Myocardial Infarction
por: Jianqing She, et al.
Publicado: (2021-12-01)

The Effect of Pentoxifylline in Reducing Proteinuria in Patients with Diabetic Nephropathy Treated with ACEI or ARB
por: Iranparvar, et al.
Publicado: (2017-10-01)

ALTITUDE halted: Adverse events when aliskiren added to ACEI, ARB therapy
por: Santanu Guha, et al.
Publicado: (2012-07-01)

Effects of ACEi and ARB on post-exercise hypotension induced by exercises conducted at different times of day in hypertensive men
por: Leandro C. Brito, et al.
Publicado: (2020-11-01)

The clinical efficacy of fluticasone propionate combined with ACEI/ARB in the treatment of immunoglobulin A nephropathy
por: Liping Sun, et al.
Publicado: (2023-03-01)

Effect of antihypertensive agents ACEI/ARB and CCB on hypertensive intracerebral hemorrhage and inflammatory cytokines, serum ferritin, and serum P
por: Peiyu Li, et al.
Publicado: (2018-12-01)

A retrospective prognostic evaluation using unsupervised learning in the treatment of COVID-19 patients with hypertension treated with ACEI/ARB drugs
por: Liye Ge, et al.
Publicado: (2024-05-01)

Efficacy and safety of tripterygium glycosides combined with ACEI/ARB on diabetic nephropathy: a meta-analysis
por: Zhuan’E. Yao, et al.
Publicado: (2025-01-01)

EFFECTIVENESS OF IMMUNOSUPPRESSANTS ALONG WITH ACEI/ARBS IN TREATING PROTEINURIA IN PATIENTS WITH SOLITARY KIDNEY POST NEPHRECTOMY
por: Nadeem Azam, et al.
Publicado: (2018-10-01)

Severity of COVID-19 infection in ACEI/ARB users in specialty hospitals: A retrospective cohort study
por: Ahmed A. Alrashed, et al.
Publicado: (2021-06-01)

Long-term oral ACEI/ARB therapy is associated with disease severity in elderly COVID-19 omicron BA.2 patients with hypertension
por: Zhe Zhang, et al.
Publicado: (2023-12-01)

Systematic review and meta-analysis of the clinical outcomes of ACEI/ARB in East-Asian patients with COVID-19.
por: Nancy Xurui Huang, et al.
Publicado: (2023-01-01)

Systematic review and meta-analysis of the clinical outcomes of ACEI/ARB in East-Asian patients with COVID-19
por: Nancy Xurui Huang, et al.
Publicado: (2023-01-01)

Developing a multi-center clinical data mart of ACEI and ARB for real-world evidence (RWE)
por: Hun-Sung Kim, et al.
Publicado: (2018-12-01)

SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy
por: Mina K. Chung, et al.
Publicado: (2020-08-01)

Patient-Reported Barriers to Adherence Among ACEI/ARB Users from a Motivational Interviewing Telephonic Intervention
por: Majd Z, et al.
Publicado: (2022-10-01)

Ensemble machine learning for personalized antihypertensive treatment
por: Bertsimas, D, et al.
Publicado: (2021)

[ACEI/ARB use among high risk patients with coronary heart disease in China: a cross-sectional study].
por: Liu, J, et al.
Publicado: (2013)

Safety of ACEI/ARB use in the early (<3 months) post kidney transplant period: a systematic review and meta-analysis
por: Dahai Fu, et al.
Publicado: (2024-12-01)

Centrally acting ACE inhibitor (cACEi) and angiotensin receptor blocker (cARB) use and cognitive dysfunction in patients with SLE
por: Dorcas Beaton, et al.
Publicado: (2023-11-01)

Efficacy and safety of Abelmoschus manihot capsule combined with ACEI/ARB on diabetic kidney disease: a systematic review and meta analysis
por: Ying Tan, et al.
Publicado: (2024-01-01)

Effect of sacubitril/valsartan and ACEI/ARB on glycaemia and the development of diabetes: a systematic review and meta-analysis of randomised controlled trials
por: Ruxin Wang, et al.
Publicado: (2022-12-01)

ACEI/ARB therapy in COVID-19: the double-edged sword of ACE2 and SARS-CoV-2 viral docking
por: Chidinma L. Onweni, et al.
Publicado: (2020-07-01)

Ensemble machine learning for personalized antihypertensive treatment
por: Bertsimas, Dimitris, et al.
Publicado: (2022)

Clinical effect of milk vetch injection combined with ACEI or ARB in early diabetic nephropathy treatment: a systematic review and meta-analysis
por: Xiao-yu ZONG, et al.
Publicado: (2022-09-01)

Do outpatient statins and ACEIs/ARBs have synergistic effects in reducing the risk of pneumonia? A population-based case-control study.
por: Jiunn-Horng Kang, et al.
Publicado: (2018-01-01)

Real-world use of ACEI/ARB in diabetic hypertensive patients before the initial diagnosis of obstructive coronary artery disease: patient characteristics and long-term follow-up outcome
por: Yue Zhang, et al.
Publicado: (2020-04-01)

ACEI/ARB Medication During ICU Stay Decrease All-Cause In-hospital Mortality in Critically Ill Patients With Hypertension: A Retrospective Cohort Study Based on Machine Learning
por: Boshen Yang, et al.
Publicado: (2022-01-01)